We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.
**In this edition:**
- NICE updates: ruxolitinib and glycopyrronium cream
- LDOM in paediatric patients
- A Delphi consensus on chronic prurigo
- A systematic review of dupilumab-associated facial…
**In this edition:**
- NICE updates: ruxolitinib and glycopyrronium cream
- LDOM in paediatric patients
- A Delphi consensus on chronic prurigo
- A systematic review of dupilumab-associated facial and neck erythema
- Zinc deficiency in bullous pemphigoid
- Determinants of real-world sunscreen effectiveness
- Does gamification improve training?
- Ruxolitinib ‘super responders’ in vitiligo treatment
- Oestrogen therapy for menopausal hair loss?
- European SCC guidelines
**In this edition:**
- NICE updates: ruxolitinib and glycopyrronium cream
- LDOM in paediatric patients
- A Delphi consensus on chronic prurigo
- A systematic review of dupilumab-associated facial…
